Community-acquired pneumonia

Annals of Internal Medicine

Volumn 151, Issue 7, 2009, Pages

  Laine, Christine ^a   Williams, Sankey ^a   Niederman, Michael ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84863643573     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. American Lung Association. Trends in pneumonia and influenza morbidity and mortality, July 2007. Accessed at www.lungusa.org/atf/cf/%7B7a8d42c2-fcca-4604-8ade-7f5d5e762256%7D/ALA_LDD08_INFLUENZA_FINAL.PDF on 24 August 2009.
2. Nuorti JP, Butler JC, Farley MM, et al. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med. 2000;342:681-689. [PMID: 10706897]
3. Walker FJ, Singleton RJ, Bulkow LR, et al. Reactions after 3 or more doses of pneumococcal polysaccharide vaccine in adults in Alaska. Clin Infect Dis. 2005;40:1730-1735. [PMID: 15909258]
4. Jackson LA, Neuzil KM, Yu O, et al. Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med. 2003;348:1747-1755. [PMID: 12724480]
5. Fisman DN, Abrutyn E, Spaude KA, et al. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community- acquired pneumonia. Clin Infect Dis. 2006;42:1093-1101. [PMID: 16575726]
6. Bender JM, Ampofo K, Korgenski K, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter? Clin Infect Dis. 2008;46:1346-1352. [PMID: 18419434]
7. Gross PA, Hermogenes AW, Sacks HS, et al. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995;123:518-527. [PMID: 7661497]
8. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994;331:778-784. [PMID: 8065407]
9. Centers for Medicare & Medicaid Services. Hospital Quality Initiative Overview. Accessed at www.cms.hhs.gov/HospitalQualityInits/Downloads/Hospitaloverview.pdf on 24 August 2009.
10. Nelson JC, Jackson ML, Weiss NS, et al. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors. J Clin Epidemiol 2009; 62: 687-694.
11. Toronto Invasive Bacterial Disease Network. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis. 2005;40:1288-1297. [PMID: 15825031]
12. de Roux A, Marcos MA, Garcia E, et al. Viral community-acquired pneumonia in nonimmunocompromised adults. Chest. 2004;125:1343-1351. [PMID: 15078744]
13. Falsey AR, Hennessey PA, Formica MA, et al. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352:1749-1759. [PMID: 15858184]
14. Arancibia F, Bauer TT, Ewig S, et al. Community- acquired pneumonia due to gram-negative bacteria and pseudomonas aeruginosa: incidence, risk, and prognosis. Arch Intern Med. 2002;162:1849-1858. [PMID: 12196083]
15. El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med. 2003;167:1650-1654. [PMID: 12689848]
16. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health careassociated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007;167:1393-1399. [PMID: 17620533]
17. Mandell LA, Marrie TJ, Grossman RF, et al. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community- Acquired Pneumonia Working Group. Clin Infect Dis. 2000;31:383-421. [PMID: 10987698]
18. Graffelman AW, le Cessie S, Knuistingh Neven A, et al. Can history and exam alone reliably predict pneumonia? J Fam Pract. 2007;56:465-470. [PMID: 17543257]
19. Hopstaken RM, Witbraad T, van Engelshoven JM, et al. Inter-observer variation in the interpretation of chest radiographs for pneumonia in community- acquired lower respiratory tract infections. Clin Radiol. 2004;59:743-752. [PMID: 15262550]
20. Syrjälä H, Broas M, Suramo I, et al. Highresolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis. 1998;27:358-363. [PMID: 9709887]
21. Metersky ML, Ma A, Bratzler DW, et al. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med. 2004;169:342-347.[PMID: 14630621]
22. van der Eerden MM, Vlaspolder F, de Graaff CS, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60:672-678. [PMID: 16061709]
23. Christ-Crain M, Stolz D, Bingisser R, et al. Procalcitonin guidance of antibiotic therapy in community- acquired pneumonia: a randomized trial. Am J Respir Crit Care Med. 2006;174:84-93. [PMID: 16603606]
24. Aujesky D, Auble TE, Yealy DM, et al. Prospective comparison of three validated prediction rules for prognosis in community-acquired pneumonia. Am J Med. 2005;118:384-392. [PMID: 15808136]
25. GenIMS Investigators. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med. 2008;52:48-58.e2. [PMID: 18342993]
26. Infectious Diseases Society of America. Infectious Diseases Society of America/ American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44 Suppl 2:S27-S72. [PMID: 17278083]
27. Liapikou A, Ferrer M, Polverino E, et al. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission. Clin Infect Dis. 2009;48:377-385. [PMID: 19140759]
28. Graham WG, Bradley DA. Efficacy of chest physiotherapy and intermittent positive- pressure breathing in the resolution of pneumonia. N Engl J Med. 1978;299:624-627. [PMID: 355879]
29. Li JZ, Winston LG, Moore DH, et al. Efficacy of short-course antibiotic regimens for community-acquired pneumonia: a meta-analysis. Am J Med. 2007;120:783-790.[PMID: 17765048]
30. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. JAMA. 1997;278:2080-2084. [PMID: 9403422]
31. Kanwar M, Brar N, Khatib R, et al. Misdiagnosis of community- acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4- h antibiotic administration rule. Chest. 2007;131:1865-1869. [PMID: 17400668]
32. Feldman RB, Rhew DC, Wong JY, et al. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. Arch Intern Med. 2003;163:1718-1726. [PMID: 12885688]
33. Gleason PP, Kapoor WN, Stone RA, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia. JAMA. 1997;278:32-39. [PMID: 9207335]
34. Brown RB, Iannini P, Gross P, et al. Impact of initial antibiotic choice on clinical outcomes in community- acquired pneumonia: analysis of a hospital claimsmade database. Chest. 2003;123:1503-1511. [PMID: 12740267]
35. Martínez JA, Horcajada JP, Almela M, et al. Addition of a macrolide to a betalactam- based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia. Clin Infect Dis. 2003;36:389-395.[PMID: 12567294]
36. Lujan M, Gallego M, Fontanals D, et al. Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality. Crit Care Med. 2004;32:625-631.[PMID: 15090938]
37. International Pneumococcal Study Group. An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome. Clin Infect Dis. 2003;37:230-237.[PMID: 12856216]
38. Community-Acquired Pneumonia Organization (CAPO) Investigators. A worldwide perspective of atypical pathogens in community- acquired pneumonia. Am J Respir Crit Care Med. 2007;175:1086-1093.[PMID: 17332485]
39. Metersky ML, Ma A, Houck PM, et al. Antibiotics for bacteremic pneumonia: Improved outcomes with macrolides but not fluoroquinolones. Chest. 2007;131:466-473.[PMID: 17296649]
40. Rello J, Catalán M, Díaz E, et al. Associations between empirical antimicrobial therapy at the hospital and mortality in patients with severe community-acquired pneumonia. Intensive Care Med. 2002;28:1030-1035.[PMID: 12185421]
41. International Pneumococcal Study Group. Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia. Am J Respir Crit Care Med. 2004;170:440-444. [PMID: 15184200]
42. Micek ST, Dunne M, Kollef MH. Pleuropulmonary complications of Panton- Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest. 2005;128:2732-2738. [PMID: 16236949]
43. Salluh JI, Verdeal JC, Mello GW, et al. Cortisol levels in patients with severe community-acquired pneumonia. Intensive Care Med. 2006;32:595-598. [PMID: 16552616]
44. Salluh JI, Póvoa P, Soares M, et al. The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care. 2008;12:R76.[PMID: 18547407]
45. PROWESS Clinical Evaluation Committee. Severe community- acquired pneumonia as a cause of severe sepsis: data from the PROWESS study. Crit Care Med. 2005;33:952-961. [PMID: 15891319]
46. Fishbane S, Niederman MS, Daly C, et al. The impact of standardized order sets and intensive clinical case management on outcomes in community- acquired pneumonia. Arch Intern Med. 2007;167:1664-1669. [PMID: 17698690]
47. Musher DM, Rueda AM, Kaka AS, et al. The association between pneumococcal pneumonia and acute cardiac events. Clin Infect Dis. 2007;45:158-165. [PMID: 17578773]
48. Rhew DC, Hackner D, Henderson L, et al. The clinical benefit of in-hospital observation in 'low-risk' pneumonia patients after conversion from parenteral to oral antimicrobial therapy. Chest. 1998;113:142-146. [PMID: 9440581]
49. Nathan RV, Rhew DC, Murray C, et al. In-hospital observation after antibiotic switch in pneumonia: a national evaluation. Am J Med. 2006;119:512.e1-7. [PMID: 16750965]
50. El Solh AA, Aquilina AT, Gunen H, et al. Radiographic resolution of communityacquired bacterial pneumonia in the elderly. J Am Geriatr Soc. 2004;52:224-229. [PMID: 14728631]
51. Falguera M, Martín M, Ruiz-González A, et al. Community-acquired pneumonia as the initial manifestation of serious underlying diseases. Am J Med. 2005;118:378-383. [PMID: 15808135]